Day: December 21, 2022

San Antonio, Texas, Dec. 21, 2022 (GLOBE NEWSWIRE) — U.S. Global Investors, Inc. (NASDAQ: GROW) (the “Company”), a registered investment advisory firm with longstanding experience in global markets and specialized sectors, today announces that, following a rigorous and competitive review process, it has selected Grant Thornton LLP as its new independent registered public accounting firm. Grant Thornton LLP (GT) is the U.S. member of Grant Thornton International Ltd (GTIL). GT is a national firm with offices throughout the United States and GTIL is an international organization with member firms throughout the world. The change of the Company’s audit firm was approved by the Board of Directors (the “Board”). November Stock Buybacks In November 2022, the Company repurchased 24,795 of its shares at a net cost of around $73,600. This...

MOUNTAIN VIEW, Calif., Dec. 21, 2022 (GLOBE NEWSWIRE) — NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, today announced it will be participating in the upcoming 41st Annual J.P. Morgan Healthcare Conference in San Francisco, California. Management is scheduled to present on Thursday, January 12th, 2023 at 9:00 a.m. Pacific Time / 12:00 p.m. Eastern Time. A live webcast of this event, as well as an archived recording, will be available on the “Investors” section of the company’s website at: https://investors.neuropace.com.  About NeuroPace, Inc.Based in Mountain View, Calif., NeuroPace is a commercial-stage medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE U.S. VANCOUVER, British Columbia, Dec. 21, 2022 (GLOBE NEWSWIRE) — Rover Metals Corp. (TSXV: ROVR) (OTCQB: ROVMF) (FSE:4XO) (“Rover” or the “Company”) is pleased to announce that further to its release of November 16, 2022, Rover has received approval from the Toronto Venture Exchange (TSXV) to close the second tranche of its $0.08 Unit Financing for gross proceeds of $202,000 (the “Second Closing”). The Company will issue 2,525,000 common shares and 2,525,000 warrants. Finders’ commissions are being paid in connection with the Second Closing in the amount of cash commissions of $3,500 and finders’ warrants of 43,750. The finder’s warrants will have an exercise price of $0.12 and a useful life of two and half (2 ½) years. The shares and warrants issued under...

Actemra is the first FDA-approved monoclonal antibody to treat COVID-19 Since the beginning of the pandemic, more than one million people hospitalised with COVID-19 have been treated with Actemra worldwide Actemra is approved for this use in more than 30 countries for the treatment of COVID-19Basel, 21 December 2022 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has approved Actemra® (tocilizumab) intravenous (IV) for the treatment of COVID-19 in hospitalised adult patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO). Actemra is the first FDA-approved monoclonal antibody to treat COVID-19 and is recommended for use as a single 60-minute IV infusion....

CALGARY, Alberta, Dec. 21, 2022 (GLOBE NEWSWIRE) — LithiumBank Resources Corp. (TSX-V: LBNK) (OTCQX: LBNKF) (“LithiumBank” or the “Company”) announces the filing of the Boardwalk Lithium Brine Project Technical report entitled “Updated Indicated and Inferred Resource Estimates for LithiumBank Resources Corp.’s Boardwalk Lithium-Brine Project in West- Central Alberta, Canada” effectively dated December 20, 2022, originally announced November 7, 2022. The Technical Report includes NI 43-101 Mineral Resource Estimates of 393,000 tonnes of Indicated Lithium Carbonate Equivalent (LCE) at a grade of 71.6 mg/L and 5,808,000 tonnes of Inferred LCE at 68.0 mg/L lithium. The report is available on www.sedar.com. The Technical Report and Mineral Resource Estimates were prepared by the following Qualified Persons; Roy Eccles, P. Geol. of APEX...

MINNEAPOLIS, Dec. 21, 2022 (GLOBE NEWSWIRE) — Autoscope Technologies Corporation (NASDAQ: AATC) today announced that it intends to voluntarily delist its common shares from the Nasdaq Capital Market and to subsequently deregister its common stock under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The Company is eligible to suspend these reporting obligations because it has fewer than 300 shareholders of record. The Company intends to continue to provide shareholders with timely financial information following the conclusion of the of delisting and deregistration. Frank G. Hallowell, interim Chief Executive Officer of Autoscope Technologies Corporation, commented, “As the Company’s supply chain constraints have passed, the business’s profitability has returned to its normal levels. Due to these factors,...

NEW YORK, Dec. 21, 2022 (GLOBE NEWSWIRE) — Viveon Health Acquisition Corp. (NYSE American: VHAQ, VHAQW, VHAQR, VHAQU), a special purpose acquisition company (the “Company”), today announced that it will allow those holders of shares of the Company’s common stock sold as part of the units issued in its initial public offering who elected to redeem their common stock (“Redeeming Stockholders”) in connection with the special meeting of stockholders held today at 10:30 AM EST (the “Special Meeting”), to reverse their redemption requests by sending a DTC DWAC (Deposit/Withdrawal At Custodian) request to the Company’s transfer agent, Continental Stock Transfer & Trust Company, by 5:00 PM EST on Friday, December 23, 2022. In connection with the Special Meeting, the Company received requests to redeem 4,628,145 shares from the Redeeming...

Reference is made to the stock exchange announcement published on 8 November 2022 by Ensurge Micropower ASA (“Ensurge” or the “Company”), regarding the successful placement of new shares, through an allocation of 18,256,183 new shares in Tranche 1 and an allocation of 9,243,817 new shares in Tranche 2. As stated in the stock exchange announcement on 8 November 2022, the shares in Tranche 2 would be issued on a separate ISIN, and would not be tradable on Oslo Børs, until a listing prospectus had been approved and published.   The Financial Supervisory Authority of Norway (Norwegian: Finanstilsynet) has approved a listing prospectus dated 21 December 2022 for the listing of 9,243,817 new shares on Oslo Børs, equal to the number of new shares in Tranche 2. As a result of the approved prospectus, the 9,243,817 new shares will be listed on...

Seattle, WA, Dec. 21, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — 3DX Industries Inc. (DDDX) (the “Company” or “3DX”), a state of the art additive manufacturer specializing in 3D Metal Printing, announces its schedule of attendance in several conferences and exhibitions throughout 2023.  Roger Janssen, President and CEO of 3DX Industries states, “Along with gaining insight into the leading technologies and trends in additive manufacturing, these shows and conferences are instrumental in developing relationships with industry leaders. We will have representation at the following events in the coming year.” January 2023: Law Enforcement and Armed Forces Show. The show will take place at Venetian Expo and Caesars Forum in Las Vegas, NV. March 2023: Additive Manufacturing Users Group (AMUG) Conference. AMUG Conference brings...